BioSpace News Archive

Biotech Bay

New Data Show Genentech’s Enspryng Significantly Reduces Severity and Risk of Relapse in Neuromyelitis Optica Spectrum Disorder

Enspryng was recently approved by the U.S. Food and Drug Administration (FDA) for adults with anti-aquaporin-4 (AQP4) antibody positive NMOSD

September 10, 2020
·
13 min read
Theratechnologies Announces Launch of Trogarzo® in Germany

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that Trogarzo® will be commercially available in Germany as of tomorrow through its subsidiary, Theratechnologies Europe Limited.

September 10, 2020
·
5 min read
New Data of Chugai’s Enspryng (Satralizumab) on Risk and Severity of Relapse in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Chugai Pharmaceutical Co., Ltd. announced the presentation of new Enspryng® data on reducing relapse severity in the treatment of neuromyelitis optica spectrum disorder, a rare disease of the central nervous system.

September 10, 2020
·
7 min read
ASLAN Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference

ASLAN Pharmaceuticals, a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced its presentation at the H.C. Wainwright 22nd Annual Global Investment Conference.

September 10, 2020
·
3 min read
Medical Education Market | Outbreak of Covid-19 is Likely to Boost Adoption Online Medical Education Programs

Medical education is all about the process of giving lessons and training to the doctors as well as to their subordinates to become a trained physicians or medical practitioner.

September 10, 2020
·
4 min read
API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market: Growing Adoption of Chondroitin Sulfate to Treat Osteoarthritis to Propel Market Growth

According to the report, the global API market was valued at US$ 2.3 Bn in 2019 and is projected to expand at a CAGR of 6.5% from 2020 to 2030.

September 10, 2020
·
6 min read
Deals

Regulatory and Quality Solutions LLC (R&Q) Acquires Maetrics to Form the Largest Medical Device-Focused Global Regulatory and Quality Consultancy

Regulatory and Quality Solutions LLC —a leading provider of regulatory and quality consulting services for medical devices, in vitro diagnostic devices, and combination products— announced that it has acquired Maetrics LLC, an international leader in life sciences quality and regulatory consulting.

September 10, 2020
·
4 min read
Business

Biofidelity appoints Dr. Heiner Dreismann as ChairmanBoard strengthened ahead of completion and market launch of disruptive cancer diagnostic platform

Biofidelity Ltd, the cancer diagnostics company, announces the appointment of Dr. Heiner Dreismann, former President and CEO of Roche Molecular Systems, as Chairman with immediate effect.

September 10, 2020
·
1 min read
Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences - Sep 10, 2020

Aurinia Pharmaceuticals Inc. announced that members of the senior management team will participate in fireside chats during the following upcoming virtual investor conferences

September 10, 2020
·
1 min read
Drug Development

Electromedical Technologies and Nazarbayev University to Launch Phase I Research Program to Define Potent Electrical Frequencies Through Animal Models

Electromedical Technologies, Inc. is pleased to announce the launch of a Phase 1 research program in collaboration with Nazarbayev University to identify the most effective electrical frequencies for driving physiological responses in animal models.

September 10, 2020
·
6 min read